221 related articles for article (PubMed ID: 7041597)
1. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
[TBL] [Abstract][Full Text] [Related]
2. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.
Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM
Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956
[TBL] [Abstract][Full Text] [Related]
4. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
Zawada ET; Stinson J; Ramirez G
Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
[TBL] [Abstract][Full Text] [Related]
5. Circulatory effects of renin-angiotensin system antagonists during halothane anaesthesia in hypertensive rats.
Kaukinen S; Kataja J; Ylitalo P
Acta Anaesthesiol Scand; 1983 Feb; 27(1):81-6. PubMed ID: 6340406
[TBL] [Abstract][Full Text] [Related]
6. Active and inactive renin after a single dose of captopril in hypertensive patients.
Glorioso N; Dessi Fulgheri P; Madeddu P; Fois G; Palermo M; Cocco F; Dettori S; Rappelli A
Am J Cardiol; 1982 Apr; 49(6):1552-4. PubMed ID: 7041596
[TBL] [Abstract][Full Text] [Related]
7. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
Case DB; Atlas SA; Laragh JH
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():313s-316s. PubMed ID: 232024
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
Aldigier JC; Plouin PF; Guyene TT; Thibonnier M; Corvol P; Menard J
Am J Cardiol; 1982 Apr; 49(6):1447-52. PubMed ID: 7041584
[No Abstract] [Full Text] [Related]
9. Antihypertensive effects of angiotensin blockade: saralasin versus captopril.
Baker KM; Johns DW; Vaughan ED; Ayers CR; Carey RM
Clin Exp Hypertens (1978); 1980; 2(6):947-54. PubMed ID: 7004807
[No Abstract] [Full Text] [Related]
10. Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat.
Thurston H; Bing RF; Marks ES; Swales JD
Clin Sci (Lond); 1980 Jan; 58(1):15-20. PubMed ID: 6986225
[TBL] [Abstract][Full Text] [Related]
11. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
Weber MA; Drayer JI; Priest RT; Chen TC
Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of the hypertensive crisis by blocking the renin-angiotensin system (author's transl)].
Wambach G; Kaufmann W
MMW Munch Med Wochenschr; 1982 Jul; 124(27):638-40. PubMed ID: 6810156
[No Abstract] [Full Text] [Related]
13. Long-term efficacy of captopril in renovascular and essential hypertension.
Case DB; Atlas SA; Marion RM; Laragh JH
Am J Cardiol; 1982 Apr; 49(6):1440-6. PubMed ID: 6803561
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of captopril in hypertensive patients: comparison with saralasin.
Fagard R; Amery A; Lijnen P; Reybrouck T
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():131s-134s. PubMed ID: 396066
[TBL] [Abstract][Full Text] [Related]
15. The antihypertensive effect of captopril in severe essential, renovascular, renal and transplant renovascular hypertension.
Schwietzer G; Oelkers W
Klin Wochenschr; 1982 Aug; 60(16):839-46. PubMed ID: 6752559
[TBL] [Abstract][Full Text] [Related]
16. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
Riegger GA; Steilner H; Hayduk K; Liebau G
Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
[TBL] [Abstract][Full Text] [Related]
17. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
[TBL] [Abstract][Full Text] [Related]
18. Effect of captopril on renal hemodynamics in the treatment of resistant renal hypertension.
Björck S; Herlitz H; Nyberg G; Granerus G; Aurell M
Hypertension; 1983; 5(5 Pt 2):III152-3. PubMed ID: 6354931
[TBL] [Abstract][Full Text] [Related]
19. Prolongation of the saralasin responsive state of two-kidney, one clip Goldblatt hypertension in the rat by the orally administered converting enzyme inhibitor captopril (SQ14,225).
Weed WC; Vaughan ED; Peach MJ
Hypertension; 1979; 1(1):8-12. PubMed ID: 397195
[TBL] [Abstract][Full Text] [Related]
20. Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome.
Atkinson AB; Brown JJ; Cumming AM; Fraser R; Lever AF; Leckie BJ; Morton JJ; Robertson JI; Davies DL
Am J Cardiol; 1982 Apr; 49(6):1460-6. PubMed ID: 7041585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
